IOVANCE BIOTHERAPEUTICS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Iovance Biotherapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Iovance Biotherapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 305M shares, a 19.1% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 305M +48.8M +19.1% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 297M +72.6M +32.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 280M +55.4M +24.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 256M +68.3M +36.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 256M +98M +62.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 225M +66.9M +42.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 224M +67.2M +42.8% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 188M +30.8M +19.6% Dec 31, 2022 10-K 2024-02-28
Q3 2022 158M +1.14M +0.73% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 158M +3M +1.94% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 157M +7.85M +5.26% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 157M +10.1M +6.9% Dec 31, 2021 10-K 2023-02-28
Q3 2021 157M +10.1M +6.91% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 155M +8.36M +5.71% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 149M +22.5M +17.7% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 147M +20.5M +16.2% Dec 31, 2020 10-K 2022-02-24
Q3 2020 147M +20.4M +16.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 146M +22.6M +18.3% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 127M +3.43M +2.78% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 126M +3M +2.43% Dec 31, 2019 10-K 2021-02-25
Q3 2019 126M +28.8M +29.5% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 124M +31.1M +33.5% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 123M +33.8M +37.7% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 123M +50.3M +68.7% Dec 31, 2018 10-K 2020-02-25
Q3 2018 97.4M +25.5M +35.4% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 92.7M +30.1M +48% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 89.6M +27.3M +43.7% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 73.2M +10.9M +17.5% Dec 31, 2017 10-K 2019-02-28
Q3 2017 72M +10M +16.2% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 62.7M +4.29M +7.35% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 62.4M +13.8M +28.5% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 62.2M +13.7M +28.2% Dec 31, 2016 10-K 2018-03-12
Q3 2016 61.9M +14.1M +29.6% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 58.4M +11.2M +23.9% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 48.5M +3.64M +8.12% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 48.5M +14.8M +43.8% Dec 31, 2015 10-K 2017-03-09
Q3 2015 47.8M +20.2M +73% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 47.1M +19.9M +73.1% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 44.9M +22.8M +103% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 33.8M +13.7M +68.5% Dec 31, 2014 10-K 2016-03-11
Q3 2014 27.6M +12.6M +83.4% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 27.2M +13.9M +104% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 22.1M +21.3M +2598% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 20M +19.2M +2346% Dec 31, 2013 10-K 2015-03-16
Q3 2013 15.1M -63.2M -80.7% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 13.3M -65M -83% Jun 30, 2013 10-Q 2013-10-23
Q1 2013 819K -77.5M -99% Mar 31, 2013 10-Q 2013-10-23
Q4 2012 819K -77.2M -99% Dec 31, 2012 10-K 2014-03-28
Q3 2012 78.3M -700K -0.89% Sep 30, 2012 10-Q 2013-01-25
Q2 2012 78.3M +630K +0.81% Jun 30, 2012 10-Q/A 2012-09-10
Q1 2012 78.3M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 78M +4.36M +5.91% Dec 31, 2011 10-K 2013-09-23
Q3 2011 79M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 77.7M Jun 30, 2011 10-Q/A 2011-09-01
Q4 2010 73.6M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.